-
Review your patient charts for the past month. If national statistics are any indication, chances are many of those cases include a diagnosis of urinary tract infection (UTI).
-
-
Use of the cervical cancer vaccine may soon expand: Merck has filed with the Food and Drug Administration (FDA) for use of Gardasil (Merck & Co.; Whitehouse Station, NJ) in use in women ages 27 through 45.
-
Your next patient is a healthy, fit 45-year-old nonsmoking woman. She says her menstrual periods are now less regular, and she reports having intermittent hot flashes. Newly divorced, she is now sexually active and wonders which contraceptive is right for her. What's your recommendation?
-
While women now have more contraceptive options, many still struggle with achieving success with their chosen contraceptive method. What can clinicians do to improve method success?
-
The American Public Health Association (APHA) has just issued a policy statement calling for schools of public health, pharmacy, and medicine to include specific education around the adverse impact of douching on reproductive and maternal outcomes.
-
A new generation of physicians is reinvigorating the field of cardiac arrest research. I am grateful that two of the experts in this area have written this issue of EM Reports. After reading this, I anticipate you will place these principles into practice.
-
-
The error was as dramatic as it was unimaginable: Surgeons at Methodist Hospital in St. Louis Park, MN, recently removed the wrong kidney from a patient with kidney cancer.
-
The Joint Commission will soon be releasing a revised version of the universal protocol, reports Peter Angood, MD, vice president and chief patient safety officer for The Joint Commission.
